インスリン分泌とグルコース耐性を調節する神経内経路
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
研究者達は腸から臓への 直接的な神経経路を発見しました この経路はインスリン分泌を促進し 血糖耐性を改善し 糖尿病治療の新たな手段を 提供します
科学分野:
- 神経科学
- 内分泌学
- 胃腸内科
背景:
- インクレチンの作用は腸内ホルモンによって促進され,インスリン分泌を促進し,グルコース代謝に影響を与えます.
- 既存のモデルは,グルコースの調節における複雑な腸と臓の相互作用を完全に説明できません.
- 直接の神経接続である腸筋は特定されていますが,その役割は不明です.
研究 の 目的:
- 腸から臓までの神経経路を 特定し 機能的に特徴づける
- この神経経路がグルコース代謝とインスリン分泌を調節する役割を調査する.
主な方法:
- 腸内ニューロンの解剖学とトランスクリプトミックの分析
- 特定された神経回路の 化学的活性化
- グルコース耐性とベータ細胞機能のインビボ評価
主要な成果:
- 十二指腸の神経細胞が 臓に直接突入している
- これらのニューロンは 栄養分を感知する腸内ニューロンの下流にあります
- この経路の活性化により,ベータ細胞のカルシウム反応が増加し,インスリン分泌が強化され,インビボでグルコース耐性が改善された.
結論:
- 腸から臓への神経経路は インクレチン信号を補完します
- この経路はベータ細胞機能とグルコース代謝を 大きく調節する.
- この神経経路は,糖尿病における血糖制御を改善する可能性を秘めています.
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416


